medigraphic.com
Órgano Oficial del Instituto Nacional de Pediatría

2017, Número 3

<< Anterior Siguiente >>

Acta Pediatr Mex 2017; 38 (3)


Hemangiomas infantiles

Hernández-Zepeda C, García-Romero MT

Idioma: Español
Referencias bibliográficas: 28
Paginas: 202-207
Archivo PDF: 482.90 Kb.


FRAGMENTO

Las lesiones vasculares en lactantes y niños se clasifican principalmente en dos grupos: tumores y malformaciones vasculares. Los hemangiomas infantiles se encuentran dentro del grupo de tumores benignos junto con otros como el granuloma piógeno, hemangioendotelioma kaposiforme y el hemangioma en penacho. Sin embargo, los hemangiomas infantiles son los tumores vasculares más comunes.
Los hemangiomas infantiles se caracterizan por tener una fase de crecimiento, de estabilidad y de involución; en contraste con las malformaciones vasculares que están conformadas por capilares, arterias, venas y vasos linfáticos anómalos y crecen de manera proporcional al crecimiento del niño, generalmente sin involucionar. Existen otros hemangiomas poco comunes con una rápida involución (RICH) o hemangiomas que no involucionan (NICH); distintos a los hemangiomas infantiles.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Enjolras O, Mulliken JB. Vascular tumors and vascular malformations (new issues). Adv Dermatol. 1997;13:375-423.

  2. Denise W Metry. Infantile hemangiomas: Epidemiology, pathogenesis, clinical features, and complications. Upto Date 2016 http://www.uptodate.com/contents/infantilehemangiomas- epidemiology-pathogenesis-clinical-features- and-complications

  3. Haggstrom AN, Drolet BA, Baselga E, et al. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics. 2006;118:882-887.

  4. Hemangioma Investigator Group, Haggstrom AN, Drolet BA, et al. Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr. 2007;150:291-294.

  5. Drolet BA, Esterly NB, Frieden IJ. Hemangiomas in children. N Engl J Med.1999;341:173-181.

  6. Chiller KG, Passaro D, Frieden IJ. Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex. Arch Dermatol. 2002;138:1567-1576.

  7. Meter DW, Hebert AA. Benign cutaneous vascular tumors of infancy: when to worry, what to do. Arch Dermatol. 2000;136:905-914.

  8. FriedenIN, Eichenfield LF, Esterly NB, et al. Guidelines of care for hemangiomas of infancy. American Academy of Dermatology Guidelines/Outcomes Committee. J Am Acad Dermatol. 1997;37:631-637.

  9. Waner M, North PE, Scherer KA, et al. The nonrandom distribution of facial hemangiomas. Arch Dermatol. 2003;139:869-875.

  10. Haggstrom AN, Garzon MC, Baselga E, et al. Risk for PHACE syndrome in infants with large facial hemangiomas. Pediatrics. 2010;126:418-426.

  11. Poindexter G, Metry DW, Barkovich AJ, Frieden IJ. PHACE syndrome with intracerebral hemangiomas, heterotopia, and endocrine dysfunction. Pediatr Neurol. 2007;36:402-406.

  12. Metry D, Heyer G, Hess C, et al. Consensus Statement on Diagnostic Criteria for PHACE Syndrome. Pediatrics. 2009;124:1447-1450.

  13. Tubbs RS, Wellons JC 3rd, Iskandar BJ, Oakes WJ. Isolated flat capillary midline lumbosacral hemangiomas as indicators of occult spinal dysraphism. J Neurosurg. 2004;100:86-89.

  14. Iacobas I, Burrows PE, Frieden IJ, et al. LUMBAR: association between cutaneous infantile hemangiomas of the lower body and regional congenital anomalies. J Pediatr. 2010;157:795-801.

  15. Razon MJ, Kräling BM, Mulliken JB, Bischoff J. Increased apoptosis coincides with onset of involution in infantile hemangioma. Microcirculation. 1998;5:189-195.

  16. Metry DW, Hawrot A, Altman C, Frieden IJ. Association of solitary, segmental hemangiomas of the skin with visceral hemangiomatosis. Arch Dermatol. 2004;140:591-596.

  17. North PE, Waner M, Mizeracki A, Mihm MC Jr. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 2000; 31:11.

  18. Martinez-Perez D, Fein NA, Boon LM, Mulliken JB. Not all hemangiomas look like strawberries: uncommon presentations of the most common tumor of infancy. Pediatr Dermatol. 1995;12:1-6.

  19. Enjolras O, Mulliken JB. The current management of vascular birthmarks. Pediatr Dermatol. 1993;10:311-313.

  20. Kim HJ, Colombo M, Frieden IJ. Ulcerated hemangiomas: clinical characteristics and response to therapy. J Am Acad Dermatol. 2001;44:962-972.

  21. Ceisler EJ, Santos L, Blei F. Periocular hemangiomas: what every physician should know. Pediatr Dermatol. 2004;21:1-9.

  22. Bauland CG, Lüning TH, Smith JM, et al. Untreated hemangiomas: growth pattern and residual lesions. Plast Reconstr Surg. 2011;127:1643-1648.

  23. Denise W Metry, Management of infantile hemangiomas, Upto Date. 2013.

  24. Darrow DH, Greene AK, Mancini AJ, et al. Diagnosis and Management of Infantile Hemangioma. Pediatrics. 2015;136:e1060-1065.

  25. Püttgen K, Lucky A, Adams D, et al. Topical Timolol Maleate Treatment of Infantile Hemangiomas. Pediatrics. 2016;138-141.

  26. Boon LM, MacDonald DM, Mulliken JB. Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconstr Surg. 1999;104:1616-1623.

  27. Breur JM, de Graaf M, Breugem CC, Pasmans SG. Hypoglycemia as a result of propranolol during treatment of infantile hemangioma: a case report. Pediatr Dermatol. 2011;28:169-171.

  28. Tollefson MM, Frieden IJ. Early growth of infantile hemangiomas: what parents' photographs tell us. Pediatrics. 2012;130:e314-320.




2020     |     www.medigraphic.com